1. Home
  2. ZLAB vs CLMT Comparison

ZLAB vs CLMT Comparison

Compare ZLAB & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • CLMT
  • Stock Information
  • Founded
  • ZLAB 2013
  • CLMT 1916
  • Country
  • ZLAB China
  • CLMT United States
  • Employees
  • ZLAB N/A
  • CLMT N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • CLMT Oil & Gas Production
  • Sector
  • ZLAB Health Care
  • CLMT Energy
  • Exchange
  • ZLAB Nasdaq
  • CLMT Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • CLMT 1.3B
  • IPO Year
  • ZLAB 2017
  • CLMT 2006
  • Fundamental
  • Price
  • ZLAB $35.49
  • CLMT $16.34
  • Analyst Decision
  • ZLAB Buy
  • CLMT Strong Buy
  • Analyst Count
  • ZLAB 5
  • CLMT 6
  • Target Price
  • ZLAB $54.28
  • CLMT $20.17
  • AVG Volume (30 Days)
  • ZLAB 938.1K
  • CLMT 1.4M
  • Earning Date
  • ZLAB 08-05-2025
  • CLMT 08-08-2025
  • Dividend Yield
  • ZLAB N/A
  • CLMT N/A
  • EPS Growth
  • ZLAB N/A
  • CLMT N/A
  • EPS
  • ZLAB N/A
  • CLMT N/A
  • Revenue
  • ZLAB $418,326,000.00
  • CLMT $4,177,500,000.00
  • Revenue This Year
  • ZLAB $44.07
  • CLMT N/A
  • Revenue Next Year
  • ZLAB $49.13
  • CLMT N/A
  • P/E Ratio
  • ZLAB N/A
  • CLMT N/A
  • Revenue Growth
  • ZLAB 43.72
  • CLMT 0.68
  • 52 Week Low
  • ZLAB $16.01
  • CLMT $7.68
  • 52 Week High
  • ZLAB $44.34
  • CLMT $25.29
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.61
  • CLMT 65.95
  • Support Level
  • ZLAB $34.55
  • CLMT $14.96
  • Resistance Level
  • ZLAB $36.73
  • CLMT $15.99
  • Average True Range (ATR)
  • ZLAB 1.31
  • CLMT 0.80
  • MACD
  • ZLAB -0.56
  • CLMT -0.05
  • Stochastic Oscillator
  • ZLAB 10.59
  • CLMT 73.98

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

Share on Social Networks: